FAL-11866-40733
3 vaccinations
16 coded responses
40 check-ins
16 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 233 / VA
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
- 2020-12-28
-
2020-12-29
Survey response — days 1–6 daily, dose 1MedDRA: Palpitations — Feeling: Fair · Site: PainFree text: Heart racing sensation. Moderate symptomMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-30
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-02
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-03
- 2021-01-04
- 2021-01-11
-
2021-01-18
Dose 2 — Pfizer-BioNTech
- 2021-01-18
-
2021-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-20
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Heart racing sensation with heart rate at 152MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-25
Health check-in — day 7, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-01
Survey response — day 14, dose 2MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue is terribleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-04-19
-
2021-04-20
Pregnancy registry surveyPregnant after vaccination · Yes, I would like someone to contact me
- 2021-07-20
-
2021-10-19
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-19
-
2021-10-20
Survey response — days 1–6 daily, dose 3MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Site: Pain · Fever · Chills, Headache · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Chest pain, shortness of breath, heart rate up to 164MedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Survey response — days 1–6 daily, dose 3MedDRA: Chest pain, Dyspnoea, Emergency care, Heart rate increased — Feeling: Poor · Site: Pain · Chills, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Chest pain shortness of breath elevated heart rate. Currently in ERMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2021-10-22
Survey response — days 1–6 daily, dose 3MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Chest pain, shortness of breath, elevated heart rate. SevereMedDRA releases: 2024-11 · check-in free text available
-
2021-10-22
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-22
Call successfulCompleted over the phone
-
2021-10-23
Survey response — days 1–6 daily, dose 3MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Chest pain, shortness of breath, elevated heart rate. SevereMedDRA releases: 2024-11 · check-in free text available
-
2021-10-24
Survey response — days 1–6 daily, dose 3MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Chest pain, shortness of breath, elevated heart rate - severeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Survey response — days 1–6 daily, dose 3MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Chest pain, shortness of breath, elevated heart rate. SevereMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Survey response — day 7, dose 3MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Chest pain, shortness of breath, elevated heart rate - severeMedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Survey response — day 14, dose 3MedDRA: Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Worsening tachycardiaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-09
Survey response — day 21, dose 3MedDRA: Chest pain, Dyspnoea, Presyncope, Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Near Syncope. Continued chest pain, tachycardia, shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Survey response — day 28, dose 3MedDRA: Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Worsening tachycardiaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-11-17
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-11-23
Survey response — day 35, dose 3MedDRA: Presyncope — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pre-syncopeMedDRA releases: 2024-11 · check-in free text available
-
2021-11-30
Survey response — day 42, dose 3MedDRA: Loss of personal independence in daily activities, Muscular weakness, Presyncope, Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Continue with tachycardia. Near syncope episodes. Upper extremity weakness post near syncope episode. Unable to perform daily tasks such as wash my hair.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-30
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-01
Call successfulCompleted over the phone
- 2022-01-18
- 2022-04-19
-
2022-10-19
Survey response — 12 months, dose 3MedDRA: Heart rate increased, Hospitalisation, Pneumonia, Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Continue with tachycardia. Was recently hospitalized for pneumonia with elevated heart rate. Never hospitalized before.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-19
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-10-20
-
2022-10-20
Callback requested for06:00PM ET
-
2022-10-20
Call successfulReported to VAERS during previous contact from GDIT
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-18 | Pfizer-BioNTech | |
| 3 | 2021-10-19 | Pfizer-BioNTech | Flu |
Call center
6 call center cases
5 successful · 1 priority 2/3 (triaged and no follow up)
VAERS report filed, before or during a call: 5
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Heart racing sensation. Moderate symptom
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Heart racing sensation with heart rate at 152
Release 3 — day 14, dose 2
Symptoms: Fatigue is terrible
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Chest pain, shortness of breath, heart rate up to 164
Systemic reaction (other): Chest pain shortness of breath elevated heart rate. Currently in ER
Systemic reaction (other): Chest pain, shortness of breath, elevated heart rate. Severe
Systemic reaction (other): Chest pain, shortness of breath, elevated heart rate. Severe
Systemic reaction (other): Chest pain, shortness of breath, elevated heart rate - severe
Systemic reaction (other): Chest pain, shortness of breath, elevated heart rate. Severe
Release 10 — day 7, dose 3
Systemic reaction (other): Chest pain, shortness of breath, elevated heart rate - severe
Release 10 — day 14, dose 3
Symptoms: Worsening tachycardia
Release 10 — day 21, dose 3
Symptoms: Near Syncope. Continued chest pain, tachycardia, shortness of breath
Release 10 — day 28, dose 3
Symptoms: Worsening tachycardia
Release 10 — day 35, dose 3
Symptoms: Pre-syncope
Release 10 — day 42, dose 3
Symptoms: Continue with tachycardia. Near syncope episodes. Upper extremity weakness post near syncope episode. Unable to perform daily tasks such as wash my hair.
Release 12 — 12 months, dose 3
Symptoms: Continue with tachycardia. Was recently hospitalized for pneumonia with elevated heart rate. Never hospitalized before.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Loss of personal independence in daily activities | · | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Presyncope | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SRO | Chest pain | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Emergency care | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release